Illinois Featured Content

  • CAR-T immune therapy attacks ovarian cancer in mice with a single dose

    Aug 1, 2023 1:15 pm by Liz Ahlberg TouchstoneInsights
    Researchers: Pictured, from front left: postdoctoral researcher Diana Rose Ranoa, graduate student Claire Schane, professor emeritus of biochemistry David Kranz (front center), researcher Amber Lewis and professor emeritus of pathology Edward Roy. Photo by Fred Zwicky

    Images

    • Researchers: Pictured, from front left: postdoctoral researcher Diana Rose Ranoa, graduate student Claire Schane, professor emeritus of biochemistry David Kranz (front center), researcher Amber Lewis and professor emeritus of pathology Edward Roy. Photo by Fred Zwicky

    A CAR-T immune therapy effective at attacking late-stage ovarian cancer in mice with a single dose provides evidence that CAR-T therapies could effectively treat solid-tumor cancers.